Publications by authors named "Nancy Francois"

Claim this Profile
B
Bacterial nasopharyngeal carriage following infant immunization with pneumococcal conjugate vaccines according to a 2+1 schedule in children in South Africa: an exploratory analysis of two clinical trials.
Marta C Nunes, Marta Moreira, Anthonet Koen, Nadia van Niekerk, Lisa Jose

Expert Rev Vaccines· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of HIV status and vaccination schedule on bacterial nasopharyngeal carriage following infant immunisation with the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in South Africa.
Shabir A Madhi, Marta Moreira, Anthonet Koen, Nadia van Niekerk, Linda de Gouveia

Vaccine· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) according to different schedules in infants in South Africa: a phase III trial.
Shabir A Madhi, Anthonet Koen, Lisa Jose, Marta Moreira, Nadia van Niekerk

Expert Rev Vaccines· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and Safety of 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children With Sickle Cell Disease Between 8 Weeks and 2 Years of Age: A Phase III, Open, Controlled Study.
Sodiomon B Sirima, Alfred Tiono, Zakaria Gansané, Mohamadou Siribié, Angèle Zongo

Pediatr Infect Dis J· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of prophylactic ibuprofen and paracetamol administration on the immunogenicity and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugated vaccine (PHiD-CV) co-administered with DTPa-combined vaccines in children: An open-label, randomized, controlled, non-inferiority trial.
Oana Falup-Pecurariu, Sorin C Man, Mihai L Neamtu, Gratiana Chicin, Ginel Baciu

Hum Vaccin Immunother· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody persistence and immunologic memory in children vaccinated with 4 doses of pneumococcal conjugate vaccines: Results from 2 long-term follow-up studies.
Jacek Wysocki, Jerzy Brzostek, Ryszard Konior, Falko G Panzer, Nancy A François

Hum Vaccin Immunother· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety profile of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
Sven Arne Silfverdal, Vanessa Coremans, Nancy François, Dorota Borys, Jan Cleerbout

Expert Rev Vaccines· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status.
Shabir A Madhi, Anthonet Koen, Lisa Jose, Nadia van Niekerk, Peter V Adrian

Medicine (Baltimore)· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, Safety and Reactogenicity of a Booster Dose of the 10-Valent Pneumococcal Nontypeable H. influenzae Protein D Conjugate Vaccine Coadministered With DTPa-IPV-Hib in Dutch Children: A Randomized Controlled Trial.
Menno R van den Bergh, Judith Spijkerman, Nancy François, Kristien Swinnen, Dorota Borys

Pediatr Infect Dis J· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study.
Alassane Dicko, Yahia Dicko, Amadou Barry, Youssoufa Sidibe, Almahamoudou Mahamar

Hum Vaccin Immunother· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with DTPa vaccine in Japanese children: A randomized, controlled study.
Satoshi Iwata, Naohisa Kawamura, Haruo Kuroki, Yasunobu Tokoeda, Mitsunobu Miyazu

Hum Vaccin Immunother· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2-dose catch-up regimens in the second year of life.
Olumuyiwa O Odusanya, Yetunde A Kuyinu, Omolara A Kehinde, Fakrudeen Shafi, Nancy François

Hum Vaccin Immunother· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, open-label study of the impact of age on booster responses to the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in children in India.
Sanjay Lalwani, Sukanta Chatterjee, Jugesh Chhatwal, Anna Simon, Sudheer Ravula, Nancy Francois

Clin Vaccine Immunol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence clinical studies: can you believe what you see?
Brigitte Cheuvart, Véronique Bianco, Magalie Caubet, Martine Douha, Laurence Fissette

Hum Vaccin Immunother· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological memory and nasopharyngeal carriage in 4-year-old children previously primed and boosted with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) with or without concomitant prophylactic paracetamol.
Roman Prymula, Ahsan Habib, Nancy François, Dorota Borys, Lode Schuerman

Vaccine· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial.
Menno R van den Bergh, Judith Spijkerman, Kristien M Swinnen, Nancy A François, Thierry G Pascal

Clin Infect Dis· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children.
Alassane Dicko, Gaoussou Santara, Almahamoudou Mahamar, Youssoufa Sidibe, Amadou Barry

Hum Vaccin Immunother· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Taiwan.
Tzou-Yien Lin, Chun-Yi Lu, Luan-Yin Chang, Cheng-Hsun Chiu, Yhu-Chering Huang

J Formos Med Assoc· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial.
Alassane Dicko, Olumuyiwa O Odusanya, Abdoulbaki I Diallo, Gaoussou Santara, Amadou Barry

BMC Public Health· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine and DTPa-IPV-Hib when coadministered as a 3-dose primary vaccination schedule in The Netherlands: a randomized controlled trial.
Menno R van den Bergh, Judith Spijkerman, Nancy François, Kristien Swinnen, Dorota Borys

Pediatr Infect Dis J· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization of preterm infants with 10-valent pneumococcal conjugate vaccine.
Félix Omeñaca, Jose Manuel Merino, Juan-Carlos Tejedor, Andreas Constantopoulos, Vassiliki Papaevangelou

Pediatrics· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Chilean children.
Rosanna E Lagos, Alma E Muñoz, Myron M Levine, Alejandro Lepetic, Nancy François

Hum Vaccin· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis